Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Sequent Scientific Ltd Performance

Today's Low
122.59
arrowIcon
Today's High
124.49
52 Wk Low
74.60
arrowIcon
52 Wk High
155.50


Open

123.9

Traded Value (Cr)

10.56

Prev. Close

122.84

Face Value

2

Volume

859568

Sequent Scientific Ltd Fundamentals

Market Cap
₹ 3064.29 Cr
P/E Ratio (TTM)
0.00
P/B Ratio
4.67
Debt to Equity
0.58
ROE
-0.58
EPS (TTM)
0.00
Dividend Yield
0.00 %
Book Value
26.32

Click here to know more about Fundamentals

Sequent Scientific Ltd Financials

Sequent Scientific Ltd Financials

Sequent Scientific Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 52.79 % 52.79 % 52.79 % 52.79 %
Retail 24.44 % 25.11 % 29.25 % 28.85 %
Others 11.45 % 10.96 % 10.90 % 11.85 %
FII 6.16 % 6.12 % 6.03 % 6.26 %
Mutual Funds 5.16 % 5.02 % 1.03 % 0.25 %

Promoters

52.79%

Retail

24.44%

Others

11.45%

FII

6.16%

Mutual Funds

5.16%

Promoters

52.79%

Retail

25.11%

Others

10.96%

FII

6.12%

Mutual Funds

5.02%

Promoters

52.79%

Retail

29.25%

Others

10.90%

FII

6.03%

Mutual Funds

1.03%

Promoters

52.79%

Retail

28.85%

Others

11.85%

FII

6.26%

Mutual Funds

0.25%

Resistance and Support

₹123.31

PIVOT

resistance-arrow
Resistance
First Resistance₹124.023
Second Resistance₹125.207
Third Resistance₹125.923
support-arrow
Support
First Support₹122.123
Second Support₹121.407
Third Support₹120.223

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day925,565455,03252.94
Week859,568541,00819.99
1 Month859,568433,55119.99
6 Months230,769,31374,319,77039.96

About Sequent Scientific Ltd

Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.

Managing Director

K R Ravishankar

Founded

1985

NSE Symbol

SEQUENT

Sequent Scientific Ltd Management

NameDesignation
Kausalya SanthanamNon-Exec. & Independent Dir.
K R Ravishankar Chairman & Managing Director
Sharat NarasapurJoint Managing Director
Gopakumar G Nair Director
Krunal ShahCompany Sec. & Compli. Officer
Kannan Ramanujam Director
Neeraj BharadwajNon-Exec & Non-Independent Dir
Gautam Kumar Das Executive Director
Gregory John AndrewsNon-Exec & Non-Independent Dir
Preetham Hebbar Company Secretary
Fabian KauscheNon-Exec & Non-Independent Dir
Kamal K SharmaChairman & Independent Directo
Milind SarwateNon-Exec. & Independent Dir.
N RajaramManaging Director & CEO
Hari Babu BodepudiDirector
PHILLIP TROTTCompany Sec. & Compli. Officer

Sequent Scientific Ltd News

Sequent Scientific reports consolidated net loss of Rs 0.91 crore in the March 2024 quarter
Sales decline 1.49% to Rs 361.20 crore
Sequent Scientific to conduct board meeting
On 15 May 2024
Sequent Scientific Jt. MD resigns
With effect from 30 April 2024
Sequent Scientific reports consolidated net profit of Rs 8.27 crore in the December 2023 quarter
Sales decline 12.24% to Rs 329.36 crore
Sequent Scientific announces board meeting date
On 13 February 2024
Sequent Scientific reports consolidated net loss of Rs 8.38 crore in the September 2023 quarter
Sales rise 2.48% to Rs 345.97 crore
Sequent Scientific announces board meeting date
On 6 November 2023
Sequent Scientific CFO Patri Venkat Raghavendra Rao resigns
Rao will continue in his current role till the close of business hours on 25 October 2023.
Sequent Scientific jumps after board approves API facility sale
Sequent Scientific rose 6.48% to Rs 93.60 after the company's board approved the sale or transfer of the API facility located in Tarapur, Maharashtra.
Sequent Scientific to conduct AGM
On 30 August 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Sun Pharmaceuticals Industries Ltd₹ 363739.18 Cr
₹ 1,516.00
(0.34 %)
119.64
Cipla Ltd₹ 126345.07 Cr
₹ 1,564.75
(1.31 %)
34.03
Divis Laboratories Ltd₹ 121812.91 Cr
₹ 4,588.60
(-0.11 %)
77.26
Zydus Lifesciences Ltd₹ 111646.69 Cr
₹ 1,109.55
(1.75 %)
32.35
Dr Reddys Laboratories Ltd₹ 101516.8 Cr
₹ 6,085.25
(-0.17 %)
23.38

Sequent Scientific Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Sequent Scientific Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Sequent Scientific Ltd's share price is ₹122.84 as of June 14, 2024 at 04:14 PM

Sequent Scientific Ltd's P/E ratio is 0.00 times as of June 14, 2024 at 04:14 PM.

Sequent Scientific Ltd's most recent financial reports indicate a price-to-book ratio of 4.67, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Sequent Scientific Ltd's market is 3,064 Cr as on June 14, 2024 at 04:14 PM.

The current financial records of Sequent Scientific Ltd show a -0.58% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Sequent Scientific Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

The 52-week high/low price of a Sequent Scientific Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Sequent Scientific Ltd's 52-week high and low as of June 14, 2024 at 04:14 PM are ₹155.5 and ₹74.6 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Sequent Scientific Ltd stands at 52.79%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 6.12% to 6.16%.